U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.483+14A>G AND Maturity onset diabetes mellitus in young

Germline classification:
Benign (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002463700.1

Allele description [Variation Report for NM_000162.5(GCK):c.483+14A>G]

NM_000162.5(GCK):c.483+14A>G

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.483+14A>G
HGVS:
  • NC_000007.14:g.44150942T>C
  • NG_008847.2:g.52229A>G
  • NM_000162.5:c.483+14A>GMANE SELECT
  • NM_001354800.1:c.483+14A>G
  • NM_033507.3:c.486+14A>G
  • NM_033508.3:c.480+14A>G
  • LRG_1074t1:c.483+14A>G
  • LRG_1074t2:c.486+14A>G
  • LRG_1074:g.52229A>G
  • NC_000007.13:g.44190541T>C
  • NM_000162.3:c.483+14A>G
Links:
dbSNP: rs74852379
NCBI 1000 Genomes Browser:
rs74852379
Molecular consequence:
  • NM_000162.5:c.483+14A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354800.1:c.483+14A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_033507.3:c.486+14A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_033508.3:c.480+14A>G - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Maturity onset diabetes mellitus in young (MODY)
Synonyms:
Mason type diabetes
Identifiers:
MONDO: MONDO:0018911; MedGen: C0342276; Orphanet: 552; OMIM: 606391; Human Phenotype Ontology: HP:0004904

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002605229Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
criteria provided, single submitter

(K & H Uppaluri Personalized Medicine Clinic Variant Classification & Assertion Criteria_Updated V.1)		Benignunknownresearch

PubMed (6)
[See all records that cite these PMIDs]

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedresearch

Citations

PubMed

Clinical implications of the glucokinase impaired function - GCK MODY today.

Hulín J, Škopková M, Valkovičová T, Mikulajová S, Rosoľanková M, Papcun P, Gašperíková D, Staník J.

Physiol Res. 2020 Dec 22;69(6):995-1011. Epub 2020 Nov 2. Review.

PubMed [citation]
PMID:
33129248
PMCID:
PMC8549873

GCK mutations in Chinese MODY2 patients: a family pedigree report and review of Chinese literature.

Ping Xiao Y, Hua Xu X, Lan Fang Y, Jiang L, Chen C, Liang L, Lin Wang C.

J Pediatr Endocrinol Metab. 2016 Aug 1;29(8):959-64. doi: 10.1515/jpem-2015-0354. Review.

PubMed [citation]
PMID:
27269892
See all PubMed Citations (6)

Details of each submission

From Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic, SCV002605229.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providedresearch PubMed (6)

Description

Potent mutations in GCK gene is associated with poor secretion of insulin. Its associated with milder forms of diabetes, which can be controlled by diet . However, there is no sufficient evidence to ascertain the significance of rs74852379 in MODY, yet.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024